Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose We evaluated the role of adjuvant therapy in stage IIIA endometrioid adenocarcinoma patients who underwent surgery followed by radiotherapy (RT) alone or chemoradiotherapy (CTRT) according to risk group. Materials and Methods A multicenter retrospective study was conducted including patients with surgical stage IIIA endometrial cancer treated by radical surgery and adjuvant RT or CTRT. Disease-free survival (DFS) and overall survival (OS) were analyzed. Results Ninety-three patients with stage IIIA disease were identified. Nineteen patients (20.4%) experienced recurrence, mostly distant metastasis (17.2%). Combined CTRT did not affect DFS (74.1% vs. 82.4%, p=0.130) or OS (96.3% vs. 91.9%, p=0.262) in stage IIIA disease compared with RT alone. Patients with age ! 60 years, grade G2/3, and lymphovascular space involvement had a significantly worse DFS and those variables were defined as risk factors. The high-risk group showed a significant reduction in 5-year DFS (! 2 risk factors) (49.0% vs. 88.0%, p < 0.001) compared with the low-risk group (< 2). Multivariate analysis confirmed that more than one risk factor was the only predictor of worse DFS (hazard ratio, 5.45; 95% confidence interval, 2.12 to 13.98; p < 0.001). Of patients with no risk factors, a subset treated with RT alone showed an excellent 5-year DFS and OS (93.8% and 100%, respectively). Conclusion We identified a low-risk subset of stage IIIA endometrioid adenocarcinoma patients who might be reasonable candidates for adjuvant RT alone. Further randomized studies are needed to determine which subset might benefit from combined CTRT.
Abstract
Purpose We evaluated the role of adjuvant therapy in stage IIIA endometrioid adenocarcinoma patients who underwent surgery followed by radiotherapy (RT) alone or chemoradiotherapy (CTRT) according to risk group. Materials and Methods A multicenter retrospective study was conducted including patients with surgical stage IIIA endometrial cancer treated by radical surgery and adjuvant RT or CTRT. Disease-free survival (DFS) and overall survival (OS) were analyzed. Results Ninety-three patients with stage IIIA disease were identified. Nineteen patients (20.4%) experienced recurrence, mostly distant metastasis (17.2%). Combined CTRT did not affect DFS (74.1% vs. 82.4%, p=0.130) or OS (96.3% vs. 91.9%, p=0.262) in stage IIIA disease compared with RT alone. Patients with age ! 60 years, grade G2/3, and lymphovascular space involvement had a significantly worse DFS and those variables were defined as risk factors. The high-risk group showed a significant reduction in 5-year DFS (! 2 risk factors) (49.0% vs. 88.0%, p < 0.001) compared with the low-risk group (< 2). Multivariate analysis confirmed that more than one risk factor was the only predictor of worse DFS (hazard ratio, 5.45; 95% confidence interval, 2.12 to 13.98; p < 0.001). Of patients with no risk factors, a subset treated with RT alone showed an excellent 5-year DFS and OS (93.8% and 100%, respectively). Conclusion We identified a low-risk subset of stage IIIA endometrioid adenocarcinoma patients who might be reasonable candidates for adjuvant RT alone. Further randomized studies are needed to determine which subset might benefit from combined CTRT.
참고문헌 (20)
- Jobsen JJ, "The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor", Gynecol Oncol, 117, pp.32~36 (2010)
- Kato T, "New revised FIGO 2008 staging system for endometrial cancer produces better discrimination in survival compared with the 1988 staging system", J Surg Oncol, 106, pp.938~941 (2012)
- Connell PP, "The significance of adnexal involvement in endometrial carcinoma", Gynecol Oncol, 74, pp.74~79 (1999)
- Denschlag D, "Stage III endometrial cancer : preoperative predictability, prognostic factors, and treatment outcome", Am J Obstet Gynecol, 196(546), pp.1~7 (2007)
- Lum MM, "Survival analysis of cancer patients with FIGO stage IIIA endometrial cancer", Am J Clin Oncol, 38, pp.283~288 (2015)
- Havrilesky LJ, "Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer", Gynecol Oncol, 114, pp.279~283 (2009)
- Lewin SN, "Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer", Obstet Gynecol, 116, pp.1141~1149 (2010)
- Eun Cheol Choi, "Postoperative radiotherapy for endometrial cancer", Radiation oncology journal, 30(3), pp.108~116 (2012), 대한방사선종양학회[DOI]
- Schorge JO, "The effect of postsurgical therapy on stage III endometrial carcinoma", Gynecol Oncol, 63, pp.34~39 (1996)
- Kuku S, "Adjuvant therapy in stage III endometrial cancer : treatment outcomes and survival : a single-institution retrospective study", Int J Gynecol Cancer, 23, pp.1056~1064 (2013)
- Nakayama K, "Concomitant postoperative radiation and chemotherapy following surgery was associated with improved overall survival in patients with FIGO stages III and IV endometrial cancer", Int J Clin Oncol, 15, pp.440~446 (2010)
- Hogberg T, "Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer : results from two randomised studies", Eur J Cancer, 46, pp.2422~2431 (2010)
- Alvarez Secord A, "The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer", Gynecol Oncol, 107, pp.285~291 (2007)
- Kuoppala T, "Surgically staged high-risk endometrial cancer:randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy", Gynecol Oncol, 110, pp.190~195 (2008)
- Mariani A, "Assessment of prognostic factors in stage IIIA endometrial cancer", Gynecol Oncol, 86, pp.38~44 (2002)
- AlHilli MM, "Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer", Gynecol Oncol, 133, pp.485~493 (2014)
- Marchetti C, "Use of adjuvant therapy in patients with FIGO stage III endometrial carcinoma : a multicenter retrospective study", Oncology, 81, pp.104~112 (2011)
- Jobsen JJ, "Outcome of endometrial cancer stage IIIA with adnexa or serosal involvement only", Obstet Gynecol Int, 2011, pp.962518~ (2011)
- Lan C, "The outcome and efficacy of adjuvant chemotherapy alone in patients with stage IIIA endometrial carcinoma with solitary adnexal involvement : a retrospective single-institution study", Gynecol Oncol, 135, pp.446~450 (2014)
- Ashman JB, "Outcome of endometrial carcinoma patients with involvement of the uterine serosa", Gynecol Oncol, 82, pp.338~343 (2001)